The Prognostic Value of CD133 in Predicting the Relapse and Recurrence Pattern of High-Grade Gliomas on MRI: A Meta-Analysis

Overview of attention for article published in Frontiers in oncology, September 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 28,479 followers.

RT @weldeiry: Frontiers | The Prognostic Value of CD133 in Predicting the Relapse and Recurrence Pattern of High-Grade Gliomas on MRI: A Me…

02 Sep 2021

Reply Repost Favourite

Frontiers | The Prognostic Value of CD133 in Predicting the Relapse and Recurrence Pattern of High-Grade Gliomas on MRI: A Meta-Analysis | Oncology https://t.co/ZOU9LgbUAw

02 Sep 2021

Reply Repost Favourite

RT @FrontOncology: New research: The Prognostic Value of CD133 in Predicting the Relapse and Recurrence Pattern of High-Grade Gliomas on MR…

02 Sep 2021

Reply Repost Favourite

New research: The Prognostic Value of CD133 in Predicting the Relapse and Recurrence Pattern of High-Grade Gliomas on MRI: A Meta-Analysis: Background Cancer stem cells have been implicated in tumor relapse, tumor invasion, and cancer therapy… https://t.co

02 Sep 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.